Brick & Kyle Associates’s CytRx Corp CYTR Stock Holding History

Brick & Kyle Associates’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-72	Closed	–	–	422
2017 Q1	$0	Hold	72	–	–	﹤0.01%	454
2016 Q4	$0	Hold	72	–	–	﹤0.01%	454
2016 Q3	$0	Hold	72	–	–	﹤0.01%	458
2016 Q2	$1K	Hold	72	–	–	﹤0.01%	430
2016 Q1	$1K	Hold	72	–	–	﹤0.01%	426
2015 Q4	$1K	Hold	72	–	–	﹤0.01%	416
2015 Q3	$1K	Hold	72	–	–	﹤0.01%	423
2015 Q2	$2K	Hold	72	–	–	﹤0.01%	435
2015 Q1	$1K	Hold	72	–	–	﹤0.01%	448
2014 Q4	$1K	Buy	+72	New	+$1.12K	﹤0.01%	433

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Brick & Kyle Associates's CYTR Position: Q2 2017 in Review

Brick & Kyle Associates sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 72 shares.

Brick & Kyle Associates first reported a position in CYTR in Q4 2014 and held it in 10 quarters. The position peaked at $2K in Q2 2015. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

Brick & Kyle Associates reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
Brick & Kyle Associates sold 72 CytRx Corp shares in Q2 2017.
Brick & Kyle Associates first reported a position in CytRx Corp in Q4 2014 and held it in 10 quarters.
Brick & Kyle Associates's CytRx Corp position peaked at $2K in Q2 2015.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.